Skip to Content

Watson 369 5 mg (Loxapine Succinate 5 mg)

Pill with imprint Watson 369 5 mg is White, Capsule-shape and has been identified as Loxapine Succinate 5 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 369 5 mg

Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg
Loxapine succinate 5 mg Watson 369 5 mg

Loxapine Succinate

Imprint
Watson 369 5 mg
Strength
5 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antipsychotic agents
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-0369
Inactive Ingredients
lactose anhydrous, benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, magnesium stearate, methylparaben, polacrilin potassium, propylparaben, sodium lauryl sulfate, sodium propionate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.